A licensed clinical dietician, preferably with experience of the management of severe and moderate acute malnutrition [SAM/MAM] in low or middle-income settings is required to work on research projects with Professor Sharon Cox. Experience of designing, conducting and analyzing dietary assessments including food frequency questionnaires, 24-hour recall and food diaries would be advantageous. Previous research and management experience would be highly advantageous. Duties will include contributing to the development of research protocols, preparing SOPs, supervision of data collection and analysis of individual dietary intake data. Specifically, this includes an observational study to document the prevalence of malnutrition in acutely unwell patients admitted to a TB ward in The Philippines and its association with in-patient mortality and TB-treatment outcomes. This would involve working with local clinical dieticians to determine current practice and training and supervision of clinical research assistants in data collection. The aim of this research is to develop appropriate interventions to improve diagnosis and management of SAM and MAM to be tested in clinical trials. Further studies are in development for outpatients with TB and in hospitalized pediatric patient populations in The Philippines and elsewhere.
Qualifications:
Required:
• Clinical Dietetics license in home country, equivalent to BSc or above.
• High standard of written and spoken English
Desirable:
• PhD in a relevant topic or relevant MSc with research experience.
• Work and research experience as outlined in the job description.
The position is to be based in Nagasaki, Japan or Manila, Philippines (for Filipino applicants) with a minimum of a 2-3 month period based in Manila.
Please send a cover letter and CV by the 18th May to sharoncox@nagasaki-u.ac.jp with "clinical dietitian researcher application" in the subject header. Pre-application enquiries to this address are also welcomed. Interviews are expected between 25-27th May. The position is available as soon as possible from 1st June 2016 for 9-12 months in the first instance.